IFT80 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.435800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.924000E-01
Normal-vs-Stage2
3.482400E-01
Normal-vs-Stage3
8.140400E-03
Normal-vs-Stage4
9.931800E-01
Stage1-vs-Stage2
1.269560E-01
Stage1-vs-Stage3
2.464100E-02
Stage1-vs-Stage4
9.151000E-01
Stage2-vs-Stage3
7.548100E-02
Stage2-vs-Stage4
2.808200E-01
Stage3-vs-Stage4
1.422210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.364200E-01
Normal-vs-AfricanAmerican
8.894200E-01
Normal-vs-Asian
1.919180E-01
Caucasian-vs-AfricanAmerican
4.407000E-01
Caucasian-vs-Asian
2.346600E-01
AfricanAmerican-vs-Asian
2.474400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.179400E-01
Normal-vs-Female
6.061800E-01
Male-vs-Female
1.964210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.753600E-01
Normal-vs-Age(41-60Yrs)
6.889200E-01
Normal-vs-Age(61-80Yrs)
3.818600E-01
Normal-vs-Age(81-100Yrs)
1.682630E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.621400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.651800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.055600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.171600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.976100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.147000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.154600E-01
Normal-vs-Daily Drinker
1.575410E-01
Normal-vs-Weekly Drinker
1.217220E-01
Normal-vs-Occasional Drinker
8.480600E-01
Normal-vs-Social Drinker
6.599200E-01
Non Drinker-vs-Daily Drinker
4.953000E-01
Non Drinker-vs-Weekly Drinker
7.495200E-01
Non Drinker-vs-Occasional Drinker
4.861700E-02
Non Drinker-vs-Social Drinker
1.720990E-01
Daily Drinker-vs-Weekly Drinker
7.672800E-01
Daily Drinker-vs-Occasional Drinker
2.295700E-02
Daily Drinker-vs-Social Drinker
8.077900E-02
Weekly Drinker-vs-Occasional Drinker
3.606500E-02
Weekly Drinker-vs-Social Drinker
1.387010E-01
Occasional Drinker-vs-Social Drinker
3.498800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.771430E-01
Normal-vs-Grade 2
1.719900E-02
Normal-vs-Grade 3
3.574300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.456400E-01
Grade 1-vs-Grade 3
4.187000E-01
Grade 1-vs-Grade 4
1.771430E-01
Grade 2-vs-Grade 3
5.476800E-01
Grade 2-vs-Grade 4
1.719900E-02
Grade 3-vs-Grade 4
3.574300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.382410E-01
Normal-vs-NonDiabetic
5.020600E-01
Diabetic-vs-NonDiabetic
6.757900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.811800E-01
Normal-vs-NoPancreatitis
4.123400E-01
Pancreatitis-vs-NoPancreatitis
9.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.880800E-01
Normal-vs-N1
3.546200E-01
N0-vs-N1
7.258200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.263200E-01
Normal-vs-TP53-NonMutant
7.274800E-01
TP53-Mutant-vs-TP53-NonMutant
3.654200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
